Group and Individual Mindfulness-Based Cognitive Therapy (MBCT) Are Both Effective: a Pilot Randomized Controlled Trial in Depressed People with a Somatic Disease
M. Schroevers, K. Tovote, E. Snippe, J. Fleer
Mindfulness July 21, 2016 DOI: 10.1007/s12671-016-0575-z (opens in new tab) via Semantic Scholar
Summary
AI-generated from the abstractBoth group-based and individually delivered mindfulness-based cognitive therapy (MBCT) were associated with improvements in depressive symptoms, anxiety, positive well-being, mindfulness, and self-compassion in adults with a chronic somatic condition and comorbid depressive symptoms. In this pilot randomized controlled trial, 56 participants with a somatic disease and Beck Depression Inventory-II score of 14 or higher were assigned to group MBCT or individual MBCT. Assessments at pre-intervention, post-intervention, and 3-month follow-up showed significant improvements in all outcomes for both formats, with no significant differences between them. The authors note the preliminary nature of the findings due to the pilot design and lack of a control group.
Study at a glance
| Characteristics | Pilot randomized controlled trial Peer reviewed |
|---|---|
| Sample size | 56 |
| Population | Adults with a chronic somatic condition and comorbid depressive symptoms (BDI-II ≥14) |
| Intervention | Mindfulness-based cognitive therapy (MBCT) |
| Duration | 8-week intervention, 3-month follow-up |
| Keywords | Psychology Medicine |
| Key finding | Both group MBCT and individual MBCT were associated with significant improvements in depressive symptoms, anxiety, positive well-being, mindfulness, and self-compassion, with no significant differences between the two formats. |
Abstract
Depressive symptoms are commonly reported by individuals suffering from a chronic medical condition. Mindfulness-based cognitive therapy (MBCT) has been shown to be an effective psychological intervention for reducing depressive symptoms in a range of populations. MBCT is traditionally given in a group format. The aim of the current pilot RCT was to examine the effects of group-based MBCT and individually based MBCT for reducing depressive symptoms in adults suffering from one or more somatic diseases. In this study, 56 people with a somatic condition and comorbid depressive symptoms (i.e., Beck Depression Inventory-II [BDI-II] ≥14) were randomized to group MBCT (n = 28) or individual MBCT (n = 28). Patients filled out questionnaires at three points in time (i.e., pre-intervention, post-intervention, 3 months follow-up). Primary outcome measure was severity of depressive symptoms. Anxiety and positive well-being as well as mindfulness and self-compassion were also assessed. We found significant improvements in all outcomes in those receiving group or individual MBCT, with no significant differences between the two conditions regarding these improvements. Although preliminary (given the pilot nature and lack of control group), results suggest that both group MBCT and individual MBCT are associated with improvements in psychological well-being and enhanced skills of mindfulness and self-compassion in individuals with a chronic somatic condition and comorbid depressive symptoms. Our findings merit future non-inferiority trials in larger samples to be able to draw more firm conclusions about the effectiveness of both formats of MBCT.